MYD88 and AL amyloidosis: MYD88 L265P is pathogenic, occurring at significant frequencies in hematologic malignancies such as chronic lymphocytic leukemia, marginal zone lymphomas of the ocular adnexa, primary central nervous system large B-cell lymphomas and multiple myeloma amongst numerous others [46,48,49,50,51,52,53].